Quantum Biopharma (QNTM) Non-cash Items (2023 - 2024)

Quantum Biopharma (QNTM) reported Non-cash Items of $4.0 million for Q3 2024, up 254.96% on a YoY basis from $1.1 million in Q4 2023, and up 254.96% sequentially from $1.1 million in Q3 2023.

Quantum Biopharma (QNTM) Non-cash Items (2023 - 2024) Analysis & Trends

Quantum Biopharma (QNTM) has 2 years of Non-cash Items data on file, last reported at $4.0 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Quantum Biopharma 2.61 Bn 2.60 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2024 4.02 Mn
Sep 30, 2024 4.02 Mn
Sep 30, 2023 1.13 Mn
Sep 30, 2023 1.13 Mn